BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35105214)

  • 21. Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy.
    Longo WE; Vernava AM; Wade TP; Coplin MA; Virgo KS; Johnson FE
    Ann Surg; 1994 Jul; 220(1):40-9. PubMed ID: 8024357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anal epidermoid carcinoma: a rare incidence or a rare diagnosis?].
    Prieto Reyes M; Vázquez Márquez L
    Rev Esp Enferm Dig; 1997 Feb; 89(2):128-32. PubMed ID: 9115820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the etiology of anal squamous carcinoma.
    Frisch M
    Dan Med Bull; 2002 Aug; 49(3):194-209. PubMed ID: 12238281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.
    Klas JV; Rothenberger DA; Wong WD; Madoff RD
    Cancer; 1999 Apr; 85(8):1686-93. PubMed ID: 10223561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin.
    Leon O; Hagberg O; Johnsson A
    Acta Oncol; 2018 Sep; 57(9):1209-1215. PubMed ID: 29490558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anal cancer and precancerous lesions: a call for improvement.
    Albuquerque A; Nathan M; Cappello C; Dinis-Ribeiro M
    Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):327-334. PubMed ID: 33714370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p16 is superior to ProEx C in identifying high-grade squamous intraepithelial lesions (HSIL) of the anal canal.
    Bala R; Pinsky BA; Beck AH; Kong CS; Welton ML; Longacre TA
    Am J Surg Pathol; 2013 May; 37(5):659-68. PubMed ID: 23552383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anal canal squamous-cell carcinomas in HIV positive patients: clinical features, treatments and prognosis].
    Vatra B; Sobhani I; Aparicio T; Girard PM; Puy Montbrun TD; Housset M; Baillet F; Hecht F; Chossidow D; Soulé JC
    Gastroenterol Clin Biol; 2002 Feb; 26(2):150-6. PubMed ID: 11938066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer of the Anal Canal: Diagnosis, Staging and Follow-Up with MRI.
    Durot C; Dohan A; Boudiaf M; Servois V; Soyer P; Hoeffel C
    Korean J Radiol; 2017; 18(6):946-956. PubMed ID: 29089827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.
    Oliveira SC; Moniz CM; Riechelmann R; Alex AK; Braghirolli MI; Bariani G; Nahas C; Hoff PM
    J Gastrointest Cancer; 2016 Mar; 47(1):75-81. PubMed ID: 26691173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines.
    Dapper H; Schiller K; Münch S; Peeken JC; Borm K; Weber W; Combs SE
    BMC Cancer; 2019 Jul; 19(1):742. PubMed ID: 31357959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Restatment. Anal Cancer].
    Vendrely V
    Rev Prat; 2021 Sep; 71(7):759-763. PubMed ID: 34792915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anal Squamous Cell Carcinoma in Ulcerative Colitis: Can Pouches Withstand Traditional Treatment Protocols?
    Lightner AL; Vaidya P; McMichael J; Click B; Regueiro M; Steele SR; Hull TL
    Dis Colon Rectum; 2021 Sep; 64(9):1106-1111. PubMed ID: 33951686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of locally advanced anal canal carcinoma with modulated arctherapy and concurrent chemotherapy].
    Troussier I; Huguet F; Servagi-Vernat S; Benahim C; Khalifa J; Darmon I; Ortholan C; Krebs L; Dejean C; Fenoglietto P; Vieillot S; Bensadoun RJ; Thariat J
    Cancer Radiother; 2015 Apr; 19(2):127-38. PubMed ID: 25770884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoradiotherapy for squamous cell anal carcinoma: a review of prognostic factors.
    Kapacee ZA; Susnerwala S; Wise M; Biswas A; Danwata F; Scott N
    Colorectal Dis; 2016 Nov; 18(11):1080-1086. PubMed ID: 27028038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inguinal Lymph Node Dissection Does Not Improve Overall Survival in Anal Cancer Nodal Disease.
    Lin ACH; Hakim A; Kellish AS; Singh P; Wozniak M; Kwiatt M; Gaughan J; Hong YK
    J Surg Res; 2020 Nov; 255():13-22. PubMed ID: 32540576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practice parameters for the diagnosis and treatment of anal intraepithelial neoplasia (AIN) on behalf of the Italian Society of Colorectal Surgery (SICCR).
    Binda GA; Gagliardi G; Dal Conte I; Verra M; Cassoni P; Cavazzoni E; Stocco E; Delmonte S; De Nardi P; Sticchi L; Mistrangelo M
    Tech Coloproctol; 2019 Jun; 23(6):513-528. PubMed ID: 31243606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and Treatment of Anal Squamous Cell Carcinoma.
    Gardner IH; Watson KM
    Dis Colon Rectum; 2020 Oct; 63(10):1358-1361. PubMed ID: 32969877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults.
    Tong WW; Hillman RJ; Kelleher AD; Grulich AE; Carr A
    HIV Med; 2014 Feb; 15(2):65-76. PubMed ID: 24007498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of human papillomavirus in anal squamous cell carcinoma.
    Ravenda PS; Magni E; Botteri E; Manzotti M; Barberis M; Vacirca D; Trovato CM; Dell'Acqua V; Leonardi MC; Sideri M; Fazio N; Zampino MG
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):1033-8. PubMed ID: 25209946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.